Go Pro
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel Free LKFT Stock Alerts

Lakefront Biotherapeutics American Depositary Shares (LKFT) Earnings Date, Estimates & Call Transcripts

Lakefront Biotherapeutics American Depositary Shares logo
$27.99 +0.47 (+1.71%)
As of 08/18/2026 04:00 PM Eastern
Compare

Lakefront Biotherapeutics American Depositary Shares Earnings Summary

Lakefront Biotherapeutics American Depositary Shares posted Q2 2026 earnings on August 10, 2026, reporting an EPS of $0.04, which topped analysts' consensus estimates of -$0.97 by $1.01. Quarterly revenue was reported to be $15.47 million, above analyst estimates of $7.29 million. With a trailing EPS of -$1.41, Lakefront Biotherapeutics American Depositary Shares' earnings are expected to decrease next year, from ($1.29) to ($1.70) per share.

Latest Q2
Earnings Date
Aug. 10Estimated
Consensus EPS
(Aug. 10)
-$0.97
Actual EPS
(Aug. 10)
$0.04 Beat By $1.01
Actual Revenue
(Aug. 10)
$15.47M

Q2 2026 Earnings Resources

Powered by Quartr
Get Lakefront Biotherapeutics American Depositary Shares Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Lakefront Biotherapeutics American Depositary Shares and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

LKFT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LKFT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Lakefront Biotherapeutics American Depositary Shares Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$0.88-$0.88-$0.88
Q2 20261-$0.91-$0.91-$0.91
Q3 20261-$0.92-$0.92-$0.92
Q4 20261-$0.94-$0.94-$0.94

Lakefront Biotherapeutics American Depositary Shares Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/10/2026Q2 2026-$0.9672$0.04+$1.0072$0.04$7.29M$15.47M
5/6/2026Q1 2026-$1.27$0.25+$1.52$0.25$11.26M$8.75M
2/15/2026Q4 2025-$13.92-$13.92-$1.06B
4/23/2025Q1 2025-$0.23-$2.47 -$2.24-$2.45$72.22M$97.33M

Lakefront Biotherapeutics American Depositary Shares Earnings - Frequently Asked Questions

Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) last announced its quarterly earning data on Monday, August 10, 2026. Learn more on LKFT's earnings history.

In the previous quarter, Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) reported $0.04 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.97) by $1.01. Learn more on analysts' earnings estimate vs. LKFT's actual earnings.

Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) has a recorded annual revenue of $1.26 billion.

Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) has a recorded net income of $363.05 million. LKFT has generated -$1.41 earnings per share over the last four quarters.

Lakefront Biotherapeutics American Depositary Shares' earnings are expected to decrease from ($1.29) per share to ($1.70) per share in the next year.

Related Companies
Earnings Tools

Earnings data for NASDAQ:LKFT is sourced from Fiscal.ai, with the most recent quarter reported on 8/10/2026. New results are added as companies report their earnings.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel